Back
Alnylam Pharmaceuticals Vs. Summit Midstream Industry Stock Comparison
Sell
40
ALNY
Alnylam Pharmaceuticals
Last Price:
$251.70
Seasonality Move:
20.34%
Sell
41
SMC
Summit Midstream
Last Price:
$29.70
Seasonality Move:
14.51%
Sell
40
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $242.61. The Score for ALNY is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Summit Midstream (SMC)
is a Sell
Is Summit Midstream a Buy, Sell or Hold?
-
The current Summit Midstream [SMC] share price is $29.68. The Score for SMC is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
SMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $242.61Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
SMC Stock Price Chart
What is Summit Midstream's stock price today?
-
The Summit Midstream share price today is $29.68Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMC is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.96 | Sell |
Relative Strength Index (14 RSI): | 48.97 | Sell |
Chaikin Money Flow: | 390735 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (231.18 - 269.82) | Sell |
Bollinger Bands (100): | (237.02 - 266.92) | Sell |
SMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.18 | Sell |
Relative Strength Index (14 RSI): | 44.16 | Sell |
Chaikin Money Flow: | 46650 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.42 - 34.92) | Sell |
Bollinger Bands (100): | (32.61 - 42.33) | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 236.26 | Buy |
20-day SMA: | 244.23 | Sell |
50-day SMA: | 250.23 | Sell |
200-day SMA: | 258.59 | Sell |
8-day EMA: | 238.33 | Buy |
20-day EMA: | 242.4 | Buy |
50-day EMA: | 248.72 | Sell |
200-day EMA: | 243.99 | Sell |
SMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.33 | Buy |
20-day SMA: | 29.91 | Sell |
50-day SMA: | 36.21 | Sell |
200-day SMA: | 36.72 | Sell |
8-day EMA: | 28.71 | Buy |
20-day EMA: | 30.25 | Sell |
50-day EMA: | 33.93 | Sell |
200-day EMA: | 34.97 | Sell |
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $1.38 per share, an increase this year of $0.96 per share, and an increase next year of $2.88 per share.
Summit Midstream Earnings Growth & SMC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alnylam Pharmaceuticals Technical Analysis
Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
10 | 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Summit Midstream Technical Analysis
Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
10 | 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |